Zura Bio Ltd — Form 10-Q
Filed August 11, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
Sandeep Kulkarni (CEO) and Marlyn Mathew (CFO) signed standard Sarbanes-Oxley Sections 302 and 906 certifications on August 11, 2026 for the 10-Q period ended June 30, 2026. Both officers attest that financial statements fairly present the company's condition and operations, and that disclosure controls and internal controls over financial reporting are effective. No exceptions, material weaknesses, deficiencies, or fraud disclosures are mentioned in these exhibits.
Why this rating
Routine SOX certification exhibits; boilerplate compliance document with no substantive business disclosure, financial impact, or operational changes disclosed.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.